Left ventricular diastolic function in normotensive type-2 diabetic subjects

Journal of the National Medical Association

Volumn 100, Issue 9, 2008, Pages 1066-1072

  Ojji, Dike ^a,c   Parsonage, Will ^b   Dooris, Mark ^b   Adebiyi, Adewole ^a   Oladapo, Oludolapo ^a   Adeleye, Jokotade ^a   Aje, Akinyemi ^a   Ogah, Okechukwu ^a   Adebayo, Adedeji ^a   Falase, Ayodele ^a   Atherton, John ^b  

^a UNIVERSITY OF IBADAN   (Nigeria)

^b ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^c UNIVERSITY OF ABUJA   (Nigeria)

Author keywords

Diabetes mellitus; Diastolic dysfunction; Left ventricular function morphology; Nigeria

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; FLOW RATE; HEART LEFT VENTRICLE FILLING; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PULMONARY VALVE; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 52649141090     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-9684(15)31446-2     Document Type: Article

References (45)

1. Zimmet PZ, McCarty DJ, Courten MP.The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J Diabetes Complications. 1997;11(2):60-68.
2. The global burden of disease: a comprehensive assessment of mortality and disability diseases, injuries, and risk factors in 1990 and projected to 2020. Geneva: World Health Organization; 1996.
3. Sobngwi E, Mauvais-Jarvis F, Vexian P, et al. Diabetes in Africans. Part 1: epidemiology and clinical specificities. Diabetes Met. (Paris). 2001;27(6):628-634.
4. Akinkugbe OO. Non-Communicable Diseases in Nigeria-Final Report of a National Survey. Lagos: Federal Ministry of Health - National Expert Committee on NCD; 1988:1-12.
5. Owoaje EE, Rotimi CN, Kaufman JS, et al. Prevalence of adult diabetes in lbadan, Nigeria. East Afr Med J. 1997;74(5):299-302.
6. Olatunbosun ST, Ojo PO, Fineberg NS, et al. Prevalence of diabetes mellitus and impaired glucose tolerance in a group of urban adults in Nigeria. J Natl Med Assoc. 1998;90(5):293-301.
7. Kannel WB, Hjortland M, Castelli WP.Role of diabetes in congestive heart failure:the Framingham study. Am J Cardiol. 1974;34(1):29-34.
8. Factor SM, Minase T, Sonnenblick EH. Clinical and morphological features of human hypertensive-diabetic cardiomyopathy. Am Heart J. 1980;99(4):446-458.
9. Akintewe TA, Adetuyibi A.Obesity and hypertension in diabetic Nigerians. Trop Geogr Med. 1986;38(2):146-149.
10. Okesina AB, Oparinde DP, Akindoyin KA, et al. Prevalence of some risk factors of coronary heart disease in a rural Nigerian population. East Afr Med J. 1999;76(4):212-216.
11. Ezenwaka CE, Akanji AO, Akanji BO, et al.The prevalence of insulin resistance and other cardiovascular disease risk factors in healthy elderly southwestern Nigerians. Atherosclerosis 1997;128(2):201-211.
12. Dubois D, Dubois EF.A formula to estimate the approximate surface area if height and weight be known. Arch intern Med. 1916;17:863-871.
13. Sahn DJ, De Maria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58(6):1072-1083.
14. Adebiyi AA, Aje A, Ogah OS, et al. Correlates of left atrial size in Nigerian hypertensives. Cardiovasc J South Afr. 2005;16(3):201-204.
15. Teichholz LE, Kreulen T, Herman MV, et al. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. Am J Cardiol. 1976; 37(1):7-11.
16. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450-458.
17. Koren MJ, Devereux RB, Casale PN, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:342.
18. Devereux RB, Dahlof B, Levy D, et al. Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial). Am J Cardiol. 1996;78(1):61-65.
19. Nishimura RA, Tajik AJ. Evaluation of Diastolic filling of left ventricle in health and Disease:Doppler Echocardiography Is the Clinician's Rosetta Stone. J Am Coll Cardiol. 1997;30:8-18.
20. Basnight MA, Gonzalez MS, Kershenovich SC, et al. Pulmonary venous flow velocity: relation to hemodynamics, mitral flow velocity and left atrial volume, and ejection fraction. J Am Soc Echocardiogr. 1991;4(6):547-558.
21. Applefon CP, Jensen JL, Hatle LK, etal. Doppler evaluation of left and right ventricular diastolic function: a technical guide for obtaining optimal flow velocity recordings. J Am Soc Echocardiogr. 1997;10(3):271-292.
22. Fang ZY, Yuda S, Anderson V, et al. Echocardiographic detection of early diabetic myocardial disease. J Am Coll Cardiol. 2003;41(4):611-617.
23. Liu JE, Palmieri V, Roman MJ, et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol. 2001;37(7):1943-1949.
24. Rotimi O, Fatusi AO, Odesanmi WO. Sudden cardiac death in Nigerians--the Ile-Ife experience. West Afr J Med. 2004;23(1):27-31.
25. Rotimi O, Ajayi AA, Odesanmi WO. Sudden unexpected death from cardiac causes in Nigerians: a review of 50 autopsied cases. Int J Cardiol. 1998;63(2):111-115.
26. Cecchi E, Pomari F, Brusasco G, et al. Preclinical left ventricular diastolic dysfunction in insulin-dependent diabetes.G Ital Cardiol. 1994; 24(7):839-844.
27. Mori H, Hazama M, Sakamoto T, et al. Clinical evaluation of the cause of left ventricular dysfunction in type 2 diabetes without significant cardiac disease. J Cardiol. 2002; 40(4):153-158.
28. Palmieri V, Bella JN, Arnett DK, et al. Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation. 2001;103(1):102-107.
29. Boyer JK, Thanigaraj S, Schechtman KB, et al. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol. 2004;93(7):870-875.
30. Poirier P, Bogaty P, Garneau C, et al. Diastolic Dysfunction in Normotensive Men with Well-Controlled Type 2 Diabetes: Importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care. 2001;24:5-10.
31. Redfield MM, Jacobsen SJ, Burnett JC, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. Jama 2003; 289(2):194-202.
32. Miller TR, Grossman SJ, Schectman KB, et al. Left ventricular diastolic filling and its association with age. Am J Cardiol. 1986;58:531-535.
33. White M, Leenen FH. Aging and cardiovascular responsiveness to beta-agonist in humans: role of changes in beta-receptor responses versus baroreflex activity. Clin Pharmacol Ther. 1994;56:50-58.
34. Lakatta EG, Yin FC. Myocardial aging: functional alterations and related cellular mechanisms. Am J Physiol. 1982;242:H927-H941.
35. Fischer M, Baessler A, Hense HW, et al. Prevalence of left ventricular diastolic dysfunction in the community.Results from a Doppler echocardiographic-based survey of a population sample. Eur Heart J. 2003;24(4):320-328.
36. Airaksinen J, Ikaheimo M, Kaila J, et al. Impaired LV filling in young female diabetics.An echocardiographic study. Acta Med Scand. 1984;216:509-516.
37. Punzengruber C, Schernthaner G, SilberbauerK, et al. LV function in well-controlled insulin-dependent (type 1) diabetics-an echocardiographic study. Cardiology. 1986;73:132-138.
38. Gough SC, Smyllie J, Barker M, et al. Diastolic dysfunction is not related to changes in glycaemic control over 6months in type 2 (non-insulin-dependent) diabetes mellitus: a cross-section study. Acta Diabetol. 1995;32:110-115.
39. Beljic T, Miric M. Improved metabolic control does not reverse LV filling abnormalities in newly diagnosed non-insulin-dependenf diabetes patients. Acta Diabetol. 1994;31:147-150.
40. Hiramatsu K, Ohara N, Shigematsu S. LV diastolic filling abnormalities in non-insulin-dependent diabetes mellitus and improvement by a short-term glycaemic control. Am J Cardiol. 1992;70:1185-1189.
41. Hirayama H, Sugano M, Abe N, et al. Troglitazone, an antidiabetic drug, improves LV mass and diastolic function in normotensive diabetic patients. Int J Cardiol. 2001;77:75-79.
42. Rubler S, Dlugash J, Yuceoglu YZ, et al. A New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30(6):595-602.
43. Galderisi M, Anderson KM, Wilson PW, et al. Echocardiographic evidence for the existence of a distinct diabetic cardiomyopathy (the Framingham Heart Study). Am J Cardiol. 1991;68(1):85-89.
44. Iozzo P, Chareonthaitawee P, Rimoldi O, et al. Mismatch between insulin-mediated glucose uptake and blood flow in the heart of patients with Type II diabetes. Diabetologia. 2002;45(10):1404-1409.
45. Shen WF, Tribouilloy C, Rey JL, et al. Prognostic significance of Doppler-derived left ventricular diastolic filling variables in dilated cardiomyopathy. Am Heart J. 1992;124(6):1524-1533.